Speaker illustration

Doctor Sarah L Ayton

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)

Potential for bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Coronary artery disease miscellaneous

Thumbnail

This platform is supported by

logo Novo Nordisk